|
Real-time Estimate
Cboe BZX
18:57:39 21/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 21.00 USD | -5.15% |
|
-17.13% | - |
| 09-16 | Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM | |
| 09-03 | Attovia Therapeutics Q2 Net Loss Widens | MT |
| Market Cap | 1.01B 881M 832M 756M 1.42B 96.98B 1.42B 9.97B 3.85B 49.31B 3.8B 3.71B 159B | P/E 2026 * |
-7.97x | P/E 2027 * | -10.6x |
|---|---|---|---|---|---|
| Enterprise Value | 632M 551M 520M 472M 885M 60.62B 889M 6.23B 2.4B 30.82B 2.37B 2.32B 99.17B | EV / Sales 2026 * |
1,354x | EV / Sales 2027 * | - |
| Free-Float |
91.15% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ATTO | Delayed | |
CBOE
| ATTO | Real-time |
Last Transcript: Attovia Therapeutics, Inc.
| 1 day | -5.15% | ||
| 1 week | -17.13% | ||
| Current month | -5.05% | ||
| 1 month | -2.31% |
| 1 week | 20.32 |  | 25.46 |
| 1 month | 18.85 | | 28 |
| Current year | 16.15 | | 28 |
| 1 year | 16.15 | | 28 |
| 3 years | 16.15 | | 28 |
| 5 years | 16.15 | | 28 |
| 10 years | 16.15 | | 28 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hangjun Zhan
CTO | Chief Tech/Sci/R&D Officer | - | 16/12/2022 |
Petter Veiby
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/06/2023 |
Tao Fu
CEO | Chief Executive Officer | 54 | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Aaron Royston
BRD | Director/Board Member | 42 | 01/06/2023 |
Tao Fu
BRD | Director/Board Member | 54 | 01/04/2023 |
James Topper
CHM | Chairman | 64 | 01/06/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 06/08/26 | Goldman Sachs & Co. LLC (Private Banking)
| Conversion | Company | 25,562,737 | 59.4081% | |
| 06/08/26 | Conversion | 1,865,710 | 4.3359% | |||
| 06/08/26 | Deep Track Capital LP
| Conversion | Company | 20,138,956 | 46.8032% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.15% | -17.13% | - | - | 1.01B | |
| +4.98% | +11.06% | +54.45% | +109.45% | 70.88B | |
| -0.09% | +0.30% | +37.90% | +83.78% | 62.49B | |
| +5.26% | +7.86% | +32.24% | +30.06% | 26.34B | |
| +2.71% | -1.09% | -14.55% | +370.52% | 26.21B | |
| +1.96% | -0.58% | -0.44% | -7.65% | 24.13B | |
| -0.02% | +7.09% | +24.81% | -11.21% | 20.72B | |
| -2.54% | -10.16% | +149.64% | +313.93% | 15.69B | |
| -0.51% | +3.47% | +46.94% | +169.51% | 14.46B | |
| -2.35% | -5.21% | -8.59% | +854.10% | 14.24B | |
| Average | +0.42% | +1.48% | +35.82% | +212.50% | 27.62B | |
| Weighted average by Cap. | +1.87% | +2.88% | +36.72% | +154.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 467K 407K 384K 349K 654K 44.78M 656K 4.6M 1.78M 22.77M 1.75M 1.71M 73.25M | - |
| Net income | -83.44M -72.76M -68.7M -62.39M -117M -8.01B -117M -823M -318M -4.07B -313M -306M -13.1B | -107M -93.43M -88.22M -80.11M -150M -10.28B -151M -1.06B -408M -5.23B -402M -394M -16.82B |
| Net Debt | -379M -330M -312M -283M -531M -36.36B -533M -3.74B -1.44B -18.49B -1.42B -1.39B -59.49B | -286M -249M -236M -214M -401M -27.45B -402M -2.82B -1.09B -13.96B -1.07B -1.05B -44.91B |
Employees
44
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/09/26 | $20.35 | -8.11% | 40,813 |
| 18/09/26 | $22.14 | -2.60% | 1,361,381 |
| 17/09/26 | $22.73 | +2.16% | 292,607 |
| 16/09/26 | $22.25 | -6.12% | 293,373 |
| 15/09/26 | $23.70 | -3.34% | 198,402 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
22.14USD
Average target price
42.20USD
Spread / Average Target
+90.61%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ATTO Stock
Select your edition
All financial news and data tailored to specific country editions
